Menu
Log in


Log in

Australia and New Zealand Consensus Position Statement: Use of COVID-19 therapeutics in patients with Haematological malignancies

5 May 2022 10:11 AM | HSANZ Main Office Sydney

Australia and New Zealand Consensus Position Statement: Use of COVID-19 therapeutics in patients with Haematological malignancies

Attached is the final version of the above consensus position statement. Click here for document



Office

145 Macquarie Street
Sydney NSW 2000
hsanz@hsanz.org.au


Follow Us

© 2023 Haematology Society of Australia & New Zealand  All Rights Reserved.

Powered by Wild Apricot Membership Software